federal_register: 2020-02163

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
2020-02163 Prescription Drug User Fee Act of 2017; Electronic Submissions and Data Standards; Public Meeting; Request for Comments Notice The Food and Drug Administration (FDA or Agency) is announcing the following public meeting entitled "Prescription Drug User Fee Act of 2017; Electronic Submissions and Data Standards." The purpose of the public meeting and the request for comments is to fulfill FDA's commitment to seek stakeholder input related to data standards and the electronic submission system's past performance, future targets, emerging industry needs, and technology initiatives. FDA will use the information from the public meeting as well as from comments submitted to the docket to inform data standards initiatives, FDA Information Technology (IT) Strategic Plan, and electronic submissions gateway target timeframes. 2020-02-05 2020 2 https://www.federalregister.gov/documents/2020/02/05/2020-02163/prescription-drug-user-fee-act-of-2017-electronic-submissions-and-data-standards-public-meeting https://www.govinfo.gov/content/pkg/FR-2020-02-05/pdf/2020-02163.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA or Agency) is announcing the following public meeting entitled "Prescription Drug User Fee Act of 2017; Electronic Submissions and Data Standards." The purpose of the public meeting and the request for comments is...  

Links from other tables